Xun Y. Xu
Distinguished in Age-Related Macular Degeneration (ARMD)

Xun Y. Xu

No. 100 Haining Road, 
Hongkou, CN 
Distinguished in Age-Related Macular Degeneration (ARMD)
No. 100 Haining Road, 
Hongkou, CN 
OverviewLocationsClinical Research

Overview

Xun Xu practices in Hongkou, China. Xu is rated as a Distinguished expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Their top areas of expertise are Diabetic Retinopathy, Nearsightedness, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy.

Their clinical research consists of co-authoring 413 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 50 articles and participated in 2 clinical trials in the study of Age-Related Macular Degeneration (ARMD).

Locations

No. 100 Haining Road, Hongkou, China
Other Locations
800 Dong Chuan Rd, Shanghai, 200240, China
No. 100 Haining Road, Shanghai, 200080, China
Haining Road 100, Shanghai, 200080, China
No.100 Haining Road, Hongkou, 200080, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1, Safety, Tolerability and Pharmacokinetic Profile Study of Intravitreous Injections of HB002.1M (a Vascular Endothelial Growth Factor Receptor Decoy) in Subjects With Neovascular Age-Related Macular Degeneration
A Phase 1, Safety, Tolerability and Pharmacokinetic Profile Study of Intravitreous Injections of HB002.1M (a Vascular Endothelial Growth Factor Receptor Decoy) in Subjects With Neovascular Age-Related Macular Degeneration
Enrollment Status: Completed
Publish Date: July 29, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-blind, Two-group Parallel, Positive-controlled Clinical Phase I Trial Comparing the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet Age-related Macular Degeneration.
A Randomized, Double-blind, Two-group Parallel, Positive-controlled Clinical Phase I Trial Comparing the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet Age-related Macular Degeneration.
Enrollment Status: Completed
Publish Date: April 11, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

412 Total Publications

Atropine or Cyclopentolate to Diagnose Premyopia in Preschool Children.
Atropine or Cyclopentolate to Diagnose Premyopia in Preschool Children.
Journal: JAMA ophthalmology
Published: September 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xu's expertise for a condition
ConditionClose
    View All 35 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile